Filing Details

Accession Number:
0001415889-24-020646
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-02 17:13:57
Reporting Period:
2024-07-31
Accepted Time:
2024-08-02 17:13:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt C/O United Therapeutics Corporation
1000 Spring Street
Silver Spring MD 20910
Chairperson & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-07-31 3,600 $129.49 3,730 No 4 M Direct
Common Stock Disposition 2024-07-31 309 $313.05 3,421 No 4 S Direct
Common Stock Disposition 2024-07-31 554 $314.03 2,867 No 4 S Direct
Common Stock Disposition 2024-07-31 222 $314.97 2,645 No 4 S Direct
Common Stock Disposition 2024-07-31 491 $317.49 2,154 No 4 S Direct
Common Stock Disposition 2024-07-31 383 $318.08 1,771 No 4 S Direct
Common Stock Disposition 2024-07-31 220 $319.55 1,551 No 4 S Direct
Common Stock Disposition 2024-07-31 551 $320.88 1,000 No 4 S Direct
Common Stock Disposition 2024-07-31 224 $321.70 776 No 4 S Direct
Common Stock Disposition 2024-07-31 496 $322.83 280 No 4 S Direct
Common Stock Disposition 2024-07-31 150 $323.84 130 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2024-07-31 3,600 $0.00 3,600 $129.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
61,469 2014-12-31 2024-12-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 166 Indirect By Spouse
Common Stock 245,909 Indirect By Trust
Common Stock 1,245 Indirect By Trust
Common Stock 28,170 Indirect By Trust
Common Stock 324,518 Indirect By Trust
Common Stock 45,596 Indirect By Trust
Footnotes
  1. This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
  2. This transaction was executed in multiple trades at prices ranging from $312.525 to $313.46. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $313.58 to $314.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $314.765 to $315.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $316.885 to $317.785. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $317.93 to $318.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $319.08 to $319.965. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $320.40 to $321.35. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $321.44 to $321.90. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $322.44 to $323.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. This transaction was executed in multiple trades at prices ranging from $323.76 to $323.915. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  13. Since the date of her last Form 4 filing, the reporting person has been replaced as the trustee of a trust which held 497 shares of Common Stock. The reporting person no longer has any reportable beneficial interest in those shares.
  14. Shares held in family trusts as to which the Reporting Person is sole trustee and members of the Reporting Person's immediate family are beneficiaries.
  15. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
  16. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
  17. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.